GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3359)

  • GC71833 structure
    GC718335-Aminolevulinic acid-d2 hydrochloride
    CAS: 187237-35-0
    Purity: >91.00%

    5-Aminolevulinic acid-d2 hydrochloride est chlorhydrate d’acide 5-aminolevulinique marqué deuterium.

  • GC71915 structure
    GC71915Tanshinone IIB
    CAS: 17397-93-2
    Purity: >99.00%

    Tanshinone IIB est un constituant actif majeur des racines de Salvia miltiorrhiza (Danshen) largement utilisé pour la recherche sur les accidents vasculaires cérébraux et les maladies coronariennes dans les pays asiatiques.

  • GC71968 structure
    GC71968Celosin K
    CAS: 1950579-53-9
    Purity: >99.00%

    Celosin K (composé 8) peut être isolé à partir de graines de Glycine.

  • GC71997 structure
    GC71997Alphitolic acid
    CAS: 19533-92-7
    Purity: >98.00%

    Alphitolic acid est un triterpénoïde pentacyclique avec un squelette de type lupane. Cette substance présente des activités anti-inflammatoire et cytotoxique.

  • GC72001 structure
    GC72001Phellamurin
    CAS: 52589-11-4

    Phellamurin est Phellamurin estinale.

  • GC72012 structure
    GC72012Dehydrocrenatidine
    CAS: 65236-62-6
    Purity: >98.00%

    Dehydrocrenatidine est un alcaloïde naturel qui est un inhibiteur spécifique de Jak.

  • GC72018 structure
    GC72018Goniothalamin
    CAS: 17303-67-2
    Purity: >98.00%

    Goniothalamin (GTN) est une lactone styrénique aux propriétés anticancéreuses, anti - inflammatoires et immunosuppressives.

  • GC72054 structure
    GC72054Obovatol
    CAS: 83864-78-2
    Purity: >99.00%

    Obovatol est un diphényléther - Lignane isolé à partir de feuilles épaisses et austères.

  • GC72061 structure
    GC72061β-Phellandrene
    CAS: 555-10-2
    Purity: >99.50%

    β-Phellandrene obtenu à partir d'os de roche.

  • GC72103 structure
    GC72103Kp7-6
    CAS: 629628-53-1
    Purity: >98.00%

    Kp7-6, un peptide mimétique du Fas, est un antagoniste du Fas/FasL.

  • GC72146 structure
    GC72146WP9QY TFA
    Purity: >99.00%

    WP9QY TFA un antagoniste du TNF - A est un peptide biologiquement actif.

  • GC72147 structure
    GC72147Mca-YVADAP-Lys(Dnp)-OH TFA
    Purity: >98.00%

    Mca-YVADAP-Lys(Dnp)-OH TFA est un substrat fluorogénique pour la caspase-1 et l’enzyme 2 ACE2 de conversion de l’angiotensine.

  • GC72183 structure
    GC72183[D-Leu-4]-OB3
    CAS: 289056-32-2
    Purity: >99.00%

    [D-Leu-4]-OB3 inhibe l’expression de gènes pro-inflammatoires, prolifératifs et métastatiques et l’expression pd-l1.

  • GC72186 structure
    GC72186WLSEAGPVVTVRALRGTGSW
    CAS: 771479-86-8
    Purity: >96.00%

    WLSEAGPVVTVRALRGTGSW est un peptide spécifique des cellules du muscle cardiaque.

  • GC72191 structure
    GC72191Pep19-2.5
    CAS: 1322711-38-5
    Purity: >98.00%

    Pep19-2.5 est un peptide synthétique et antitoxine, bloque la cascade de signalisation endotoxine intracellulaire.

  • GC72216 structure
    GC72216(Gly14)-Humanin (human) (acetate)
    Purity: >98.00%

    (Gly14)-Humanin (human) (acetate) est un analogue de humanin, dans lequel le 14ème acide aminé, la sérine, est remplacé par la Glycine (Gly).

  • GC72251 structure
    GC72251Tripeptide-32
    CAS: 1185583-20-3
    Purity: >99.00%

    Tripeptide-32 est un peptide biologiquement actif avec des effets anti - âge qui a été rapporté pour être utilisé comme ingrédient cosmétique.

  • GC72318 structure
    GC72318Tulisokibart
    CAS: 2648504-55-4
    Purity: 95.00%

    Tulisokibart (PRA023) est un anticorps monoclonal IgG1-κ humanisé ciblant TNFSF15/TL1A.

  • GC72319 structure
    GC72319Atrosab
    CAS: 1365659-05-7
    Purity: >96.00%

    Atrosab est un anticorps humanisé anti - tnfr1 Antagoniste des IgG1.

  • GC72337 structure
    GC72337Anti-Mouse 4-1BB/CD137 Antibody (3H3)
    Purity: >99.00%

    Anti-Mouse 4-1BB/CD137 Antibody (3H3) est un inhibiteur de l'anticorps igg2a anti - 4 - 1bb de souris dérivé du rat hôte.

  • GC72359 structure
    GC72359Quilizumab
    CAS: 1228538-47-3
    Purity: >96.00%

    Quilizumab (anticorps Recombinant anti - ngcgm3 humain) est un anticorps monoclonal humanisé IgG1 Kappa.

  • GC72360 structure
    GC72360Ruplizumab
    CAS: 220651-94-5
    Purity: >99.00%

    Ruplizumab (BG 9588) est un anticorps monoclonal humanisé anti - CD40L (récepteur TNF) IgG1 Kappa.

  • GC72364 structure
    GC72364Toralizumab
    CAS: 252662-47-8
    Purity: 95.00%

    Toralizumab (IDEC - 131) est un anticorps monoclonal humanisé (MAB) dirigé contre CD40L (cd154), composé de la chaîne lourde humaine γ1 et de la chaîne légère humaine κ.

  • GC72365 structure
    GC72365Visilizumab
    CAS: 219716-33-3
    Purity: >98.00%

    Visilizumab (anticorps Recombinant anti - cd3e humain) est un anticorps igg2 monoclonal anti - cd3e humanisé qui se lie au récepteur hypofc.